Cite

HARVARD Citation

    Borate, U. et al. (2012). Potential of whole-genome sequencing for determining risk and personalizing therapy: focus on AML. Expert review of anticancer therapy. 12 (10), pp. 1289-1297. [Online]. 
  
Back to record